ARCHIVES

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003